$2.08 Billion is the total value of Woodford Investment Management Ltd's 7 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | Buy | ABBVIE INC | $703,395,000 | +1.1% | 11,232,758 | +1.8% | 33.86% | +20.4% |
| PRTA | Buy | PROTHENA CORP PLC | $507,174,000 | -17.9% | 10,310,511 | +0.1% | 24.42% | -2.2% |
| ALKS | Sell | ALKERMES PLC | $414,134,000 | +16.6% | 7,451,128 | -1.3% | 19.94% | +38.9% |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $334,983,000 | -1.7% | 10,507,608 | +11.7% | 16.13% | +17.0% |
| BIIB | Buy | BIOGEN INC | $64,918,000 | +21.7% | 248,530 | +45.8% | 3.12% | +44.9% |
| GILD | Buy | GILEAD SCIENCES INC | $43,990,000 | +14.2% | 614,300 | +26.2% | 2.12% | +36.0% |
| NWBO | Sell | NORTHWEST BIOTHERAPEUTICS INC | $8,638,000 | -38.6% | 24,815,028 | -4.2% | 0.42% | -26.8% |
| RAI | Exit | REYNOLDS AMERICAN INC | $0 | – | -7,608,324 | -100.0% | -14.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-05-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PROTHENA CORP PLC | 19 | Q2 2019 | 37.7% |
| ALKERMES PLC | 18 | Q1 2019 | 28.0% |
| THERAVANCE BIOPHARMA INC | 17 | Q3 2019 | 71.3% |
| BIOGEN INC | 12 | Q1 2019 | 9.8% |
| ABBVIE INC | 9 | Q3 2017 | 33.9% |
| NORTHWEST BIOTHERAPEUTICS INC | 9 | Q4 2016 | 12.7% |
| REYNOLDS AMERICAN INC | 7 | Q3 2016 | 45.9% |
| EVOFEM BIOSCIENCES INC | 7 | Q3 2019 | 20.3% |
| AUTOLUS THERAPEUTICS PLC | 6 | Q3 2019 | 33.9% |
| GILEAD SCIENCES INC | 6 | Q4 2017 | 7.6% |
View Woodford Investment Management Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evofem Biosciences, Inc.Sold out | February 04, 2020 | 0 | 0.0% |
| Nightstar Therapeutics plcSold out | February 04, 2020 | 0 | 0.0% |
| Theravance Biopharma, Inc. | November 08, 2019 | 429,770 | 0.8% |
| Autolus Therapeutics plc | October 09, 2019 | 2,095,127 | 4.7% |
| NuCana plc | September 09, 2019 | 1,538,000 | 4.8% |
| Prothena Corp plcSold out | September 09, 2019 | 0 | 0.0% |
| NORTHWEST BIOTHERAPEUTICS INC | February 14, 2019 | 24,815,028 | 4.8% |
View Woodford Investment Management Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-04 |
| SC 13G/A | 2020-02-04 |
| 13F-HR | 2020-01-27 |
| 13F-HR/A | 2019-11-12 |
| 13F-HR | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-10-09 |
| SC 13G/A | 2019-09-09 |
| SC 13G/A | 2019-09-09 |
View Woodford Investment Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.